Ardelyx Plans Mid-2020 NDA Filing For Tenapanor In Hyperphosphatemia

SC1912_Success_325170179_1200.jpg
Aredlyx's tenapanor was successful in a second Phase III trial • Source: Shutterstock

More from Financing

More from Business